Idexx Laboratories
IDXX
1,011 hedge funds and large institutions have $35.6B invested in Idexx Laboratories in 2021 Q1 according to their latest regulatory filings, with 106 funds opening new positions, 366 increasing their positions, 371 reducing their positions, and 58 closing their positions.
83% more first-time investments, than exits
New positions opened: 106 | Existing positions closed: 58
4% more funds holding
Funds holding: 971 → 1,011 (+40)
1% less repeat investments, than reductions
Existing positions increased: 366 | Existing positions reduced: 371
5% less capital invested
Capital invested by funds: $37.5B → $35.6B (-$1.87B)
1.35% less ownership
Funds ownership: 86.61% → 85.26% (-1.4%)
24% less funds holding in top 10
Funds holding in top 10: 33 → 25 (-8)
59% less call options, than puts
Call options by funds: $78.6M | Put options by funds: $191M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$327M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$217M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$128M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$58.2M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$56.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$370M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
-$320M |
| 3 |
BAMCO Inc
New York
|
-$98.8M |
| 4 |
Neuberger Berman Group
New York
|
-$93.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$69.7M |
IDXX Hedge Fund Activity: Q1 2021 in Review
1,011 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2021, worth a combined $35.6B — down 5% from $37.5B a quarter earlier.
Buyers outnumbered sellers: 106 funds opened new IDXX positions and 58 closed out — a net gain of 48 holders — while 366 added to existing stakes and 371 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $327M. The largest seller was T. Rowe Price Associates, cutting an estimated $370M.
- 1,011 institutional investors held Idexx Laboratories (IDXX) as of Q1 2021, up from 971 in Q4 2020.
- Funds reported $35.6B of Idexx Laboratories stock for Q1 2021, down 5% quarter-over-quarter.
- 106 funds opened new Idexx Laboratories positions in Q1 2021 and 58 closed out, a net change of +48 holders.
- The largest Idexx Laboratories buyer in Q1 2021 was Fidelity Investments, an estimated $327M added.
- The largest Idexx Laboratories seller in Q1 2021 was T. Rowe Price Associates, an estimated $370M sold.
Based on aggregated 13F filings for Q1 2021.